Strata Critical Medical (SRTA) Change in Acquisitions & Divestments (2023 - 2026)

Strata Critical Medical (SRTA) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $30.5 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 71.69% year-over-year to $30.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 241.46% YoY) and the FY2025 annual result came in at $70.2 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments rose to $30.5 million in Q1 2026 per SRTA's latest filing, from -$132.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $131.2 million in Q1 2023 and bottomed at -$168.0 million in Q4 2024.
• The 4-year median for Change in Acquisitions & Divestments is $47.6 million (2025), against an average of $12.1 million.
• The widest annual swing landed in 2025, when Change in Acquisitions & Divestments climbed 20.91%; it then plunged 71.69% in 2026.
• Tracing SRTA's Change in Acquisitions & Divestments over 4 years: stood at -$110.7 million in 2023, then sank by 51.78% to -$168.0 million in 2024, then rose by 20.91% to -$132.8 million in 2025, then jumped by 122.96% to $30.5 million in 2026.
• Per Business Quant, the three latest SRTA Change in Acquisitions & Divestments figures stand at $30.5 million (Q1 2026), -$132.8 million (Q4 2025), and $51.7 million (Q3 2025).

Peer Comparison